Age, body mass index, PSA, prostate volume, number of biopsy cores, history of prostate biopsy, and presence of prostate cancer were similar among the groups (A detailed evaluation of demographic and clinical data for the PPIA and IRTA groups is shown in Table 1). This evidence concerns the gene KLK3 and prostate cancer.